Figure 2.

2N4R Tau phosphorylation frequencies in AD patient brain tissues. Only significant AD patient frequency sites (>10%) are shown. Data used for this figure were from Wesseling et al., 2022.15 The phosphorylation sites used for antibody screening in this study are highlighted in red.